Literature DB >> 15331704

Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Nobuhiko Kanazawa1, Masayuki Kurosaki, Naoya Sakamoto, Nobuyuki Enomoto, Yasuhiro Itsui, Tsuyoshi Yamashiro, Yoko Tanabe, Shinya Maekawa, Mina Nakagawa, Cheng-Hsin Chen, Sei Kakinuma, Shigeru Oshima, Tetsuya Nakamura, Takanobu Kato, Takaji Wakita, Mamoru Watanabe.   

Abstract

Cellular antiviral responses are mediated partly by the expression of interferon-stimulated genes, triggered by viral genomes, their transcripts and replicative intermediates. Persistent replication of a hepatitis C virus (HCV) replicon suggests that the replicon does not elicit cellular innate antiviral responses. In the present study, we investigated regulatory factors of the interferon-mediated antiviral system in cells expressing an HCV replicon. Luciferase reporter assays revealed that the baseline activity of the interferon-stimulated response element (ISRE) was significantly lower in cells harboring the replicon than in naive cells. Among the proteins involved in the IFN/Jak/STAT pathway and in ISRE activity, the expression level of interferon regulatory factor 1 (IRF-1) was found to be significantly lower in cells harboring the replicon. Transfection of an IRF-1 expression construct into cells harboring the replicon caused an increase of ISRE activity, accompanied by suppression of expression of the HCV replicon. Moreover, in cured Huh7 cells from which the HCV replicon had been eliminated, the expression levels of IRF-1 and ISRE activity also were suppressed, demonstrating that the decrease of IRF-1 is attributable, not to active suppression by the viral proteins, but to adaptation of cells that enables replication of the HCV subgenome. The high permissiveness of the cured cells for the replicon was abolished by transgenic supplementation of IRF-1 expression. Taken together, IRF-1 is one of the key host factors that regulate intracellular HCV replication through modulation of interferon-stimulated-gene-mediated antiviral responses. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331704      PMCID: PMC514971          DOI: 10.1128/JVI.78.18.9713-9720.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either.

Authors:  R Pine; T Decker; D S Kessler; D E Levy; J E Darnell
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

3.  Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.

Authors:  Isabella Abbate; Mario Romano; Roberta Longo; Giuseppina Cappiello; Oreste Lo Iacono; Vito Di Marco; Concetta Paparella; Alberto Spano; Maria Rosaria Capobianchi
Journal:  J Med Virol       Date:  2003-08       Impact factor: 2.327

4.  Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells.

Authors:  Qing Zhu; Ju-Tao Guo; Christoph Seeger
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.

Authors:  Takanobu Kato; Tomoko Date; Michiko Miyamoto; Akihiro Furusaka; Katsutoshi Tokushige; Masashi Mizokami; Takaji Wakita
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

6.  Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection.

Authors:  R Pine
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells.

Authors:  Shigeru Oshima; Tetsuya Nakamura; Shin Namiki; Eriko Okada; Kiichiro Tsuchiya; Ryuichi Okamoto; Motomi Yamazaki; Takanori Yokota; Masatoshi Aida; Yuki Yamaguchi; Takanori Kanai; Hiroshi Handa; Mamoru Watanabe
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells.

Authors:  Tomoko Date; Takanobu Kato; Michiko Miyamoto; Zijiang Zhao; Kotaro Yasui; Masashi Mizokami; Takaji Wakita
Journal:  J Biol Chem       Date:  2004-02-26       Impact factor: 5.157

9.  Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.

Authors:  Yoko Tanabe; Naoya Sakamoto; Nobuyuki Enomoto; Masayuki Kurosaki; Eri Ueda; Shinya Maekawa; Tsuyoshi Yamashiro; Mina Nakagawa; Cheng-Hsin Chen; Nobuhiko Kanazawa; Sei Kakinuma; Mamoru Watanabe
Journal:  J Infect Dis       Date:  2004-03-16       Impact factor: 5.226

10.  Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells.

Authors:  S Maekawa; N Enomoto; N Sakamoto; M Kurosaki; E Ueda; T Kohashi; H Watanabe; C-H Chen; T Yamashiro; Y Tanabe; N Kanazawa; M Nakagawa; C Sato; M Watanabe
Journal:  J Viral Hepat       Date:  2004-09       Impact factor: 3.728

View more
  37 in total

Review 1.  Regulation of hepatic innate immunity by hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

2.  Oncogenic Ras inhibits IRF1 to promote viral oncolysis.

Authors:  Y Komatsu; S L Christian; N Ho; T Pongnopparat; M Licursi; K Hirasawa
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

3.  Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.

Authors:  Takako Watanabe; Naoya Sakamoto; Mina Nakagawa; Sei Kakinuma; Yasuhiro Itsui; Yuki Nishimura-Sakurai; Mayumi Ueyama; Yusuke Funaoka; Akiko Kitazume; Sayuri Nitta; Kei Kiyohashi; Miyako Murakawa; Seishin Azuma; Kiichiro Tsuchiya; Shinya Oooka; Mamoru Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

4.  Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication.

Authors:  Akiko Kusano-Kitazume; Naoya Sakamoto; Yukiko Okuno; Yuko Sekine-Osajima; Mina Nakagawa; Sei Kakinuma; Kei Kiyohashi; Sayuri Nitta; Miyako Murakawa; Seishin Azuma; Yuki Nishimura-Sakurai; Masatoshi Hagiwara; Mamoru Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

5.  Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes.

Authors:  Anna R Ciccaglione; Emilia Stellacci; Cinzia Marcantonio; Valentina Muto; Michele Equestre; Giulia Marsili; Maria Rapicetta; Angela Battistini
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

6.  Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.

Authors:  Sharmila Nair; Subhajit Poddar; Raeann M Shimak; Michael S Diamond
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

7.  Essential cell-autonomous role for interferon (IFN) regulatory factor 1 in IFN-γ-mediated inhibition of norovirus replication in macrophages.

Authors:  Nicole S Maloney; Larissa B Thackray; Gautam Goel; Seungmin Hwang; Erning Duan; Punit Vachharajani; Ramnik Xavier; Herbert W Virgin
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

8.  Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3.

Authors:  Tsuyoshi Yamashiro; Naoya Sakamoto; Masayuki Kurosaki; Nobuhiko Kanazawa; Yoko Tanabe; Mina Nakagawa; Cheng-Hsin Chen; Yasuhiro Itsui; Tomoyuki Koyama; Yoshie Takeda; Shinya Maekawa; Nobuyuki Enomoto; Hiroshi Sakugawa; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

9.  Interferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells.

Authors:  Wadzanai P Mboko; Bryan C Mounce; Joseph Emmer; Eric Darrah; Shailendra B Patel; Vera L Tarakanova
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

10.  Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection.

Authors:  Quentin Lepiller; Eric Soulier; Qisheng Li; Mélanie Lambotin; Jochen Barths; Dietmar Fuchs; Françoise Stoll-Keller; T Jake Liang; Heidi Barth
Journal:  J Innate Immun       Date:  2015-03-19       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.